GlassScriptPhysician profile
Ghasan Ahmad
NPI 1093004939
$4,320.98
in general payments reported to CMS, 2019-2025
20 companies · $704 in 2025
The $704 reported for 2025 was more than what 82% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $75.46 · 2021: $58.77 · 2022: $646 · 2023: $989 · 2024: $1,704 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,854 · Food and Beverage: $1,543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,853.98 |
| Food and Beverage | $1,542.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $1,260.04 | 2022-2023 | Web Aneurysm Embolization System, Stent |
| Cordis US Corp. | $1,066.06 | 2024 | Angioguard, Ncraft Aaa Stent Graft System |
| Rapid Medical LTD | $620.21 | 2024-2025 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Medtronic, INC. | $388.01 | 2021-2025 | Percept PC Brainsense, Sensight, Strata |
| Stryker Corporation | $372.41 | 2024-2025 | Broadway 8, Trevo, Neuroform Atlas |
| Imperative Care, INC | $118.36 | 2025 | Zoom 88-T Large Distal Platform |
| E.R. Squibb & Sons, L.L.C. | $67.02 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $65.82 | 2023 | Xarelto |
| Incyte Corporation | $60.10 | 2019 | |
| Ucb, INC. | $53.12 | 2023-2024 | Briviact, Fintepla |
| Depuy Synthes Sales INC. | $48.52 | 2024 | Embotrap |
| Bayer Healthcare Pharmaceuticals INC. | $45.24 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $33.67 | 2022-2023 | Rytary |
| Livanova USA, INC. | $22.93 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Boston Scientific Corporation | $20.05 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.48 | 2020 | |
| Tanabe Pharma America, INC. | $16.46 | 2023 | |
| Edwards Lifesciences Corporation | $15.67 | 2022 | |
| Astellas Pharma US INC | $15.42 | 2020 | |
| Pfizer INC. | $14.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghasan Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.